TORISEL for Metastatic renal cell carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where TORISEL was used for Metastatic renal cell carcinoma.
Most Reported Side Effects for TORISEL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 17 | 21.8% | 4 | 3 |
| Metastatic renal cell carcinoma | 5 | 6.4% | 2 | 2 |
| Pleural effusion | 5 | 6.4% | 0 | 3 |
Other Indications for TORISEL
Other Drugs Used for Metastatic renal cell carcinoma
SUNITINIB MALATE (4,271)
NIVOLUMAB (3,857)
IPILIMUMAB (1,826)
AXITINIB (1,612)
PAZOPANIB (1,353)
CABOZANTINIB S-MALATE (1,055)
EVEROLIMUS (653)
PEMBROLIZUMAB (534)
LENVATINIB (343)
CABOZANTINIB (292)